首页 | 本学科首页   官方微博 | 高级检索  
检索        


The closing survival gap after liver transplantation for hepatocellular carcinoma in the United States
Institution:UPMC (University of Pittsburgh Medical Center), Montefiore Hospital, 3459 Fifth Avenue, N758, Pittsburgh, PA, 15213 USA
Abstract:BackgroundSocio-economic inequalities among different racial/ethnic groups have increased in many high-income countries. It is unclear, however, whether increasing socio-economic inequalities are associated with increasing differences in survival in liver transplant (LT) recipients.MethodsAdults undergoing first time LT for hepatocellular carcinoma (HCC) between 2002 and 2017 recorded in the Scientific Registry of Transplant Recipients (SRTR) were included and grouped into three cohorts. Patient survival and graft survival stratified by race/ethnicity were compared among the cohorts using unadjusted and adjusted analyses.ResultsWhite/Caucasians comprised the largest group (n=9,006, 64.9%), followed by Hispanic/Latinos (n=2,018, 14.5%), Black/African Americans (n=1,379, 9.9%), Asians (n=1,265, 9.1%) and other ethnic/racial groups (n=188, 1.3%). Compared to Cohort I (2002-2007), the 5-year survival of Cohort III (2012-2017) increased by 18% for Black/African Americans, by 13% for Whites/Caucasians, by 10% for Hispanic/Latinos, by 9% for patients of other racial/ethnic groups and by 8% for Asians (All P values<0.05). Despite Black/African Americans experienced the highest survival improvement, their overall outcomes remained significantly lower than other ethnic∕racial groups (adjusted HR for death=1.20; 95%CI 1.05-1.36; P=0.005; adjusted HR for graft loss=1.21; 95%CI 1.08-1.37; P=0.002).ConclusionThe survival gap between Black/African Americans and other ethnic/racial groups undergoing LT for HCC has significantly decreased over time. However, Black/African Americans continue to have the lowest survival among all racial/ethnic groups.
Keywords:LT"}  {"#name":"keyword"  "$":{"id":"pc_Z1NH68lh73"}  "$$":[{"#name":"text"  "_":"Liver transplantation  HCC"}  {"#name":"keyword"  "$":{"id":"pc_vFnYOlavaO"}  "$$":[{"#name":"text"  "_":"Hepatocellular carcinoma  U  S  "}  {"#name":"keyword"  "$":{"id":"pc_lacqsA27KE"}  "$$":[{"#name":"text"  "_":"United States  HR"}  {"#name":"keyword"  "$":{"id":"pc_T856qIT5CX"}  "$$":[{"#name":"text"  "_":"Hazard Ratio  HCV"}  {"#name":"keyword"  "$":{"id":"pc_OjubiJ9Mbu"}  "$$":[{"#name":"text"  "_":"Hepatitis C Virus  SRTR"}  {"#name":"keyword"  "$":{"id":"pc_zQ3abHYG1L"}  "$$":[{"#name":"text"  "_":"Scientific Registry of Transplant Recipients  HRSA"}  {"#name":"keyword"  "$":{"id":"pc_ZUmp9b4IQq"}  "$$":[{"#name":"text"  "_":"Health Resources and Services Administration  OPTN"}  {"#name":"keyword"  "$":{"id":"pc_JUYYyHXwJ4"}  "$$":[{"#name":"text"  "_":"Organ Procurement and Transplantation Network  STROBE"}  {"#name":"keyword"  "$":{"id":"pc_f8YAb9yqkO"}  "$$":[{"#name":"text"  "_":"Strengthening of the Reporting of Observational Studies in Epidemiology  MELD"}  {"#name":"keyword"  "$":{"id":"pc_ItgcVFkR7k"}  "$$":[{"#name":"text"  "_":"Model for End Stage Liver Disease  AFP"}  {"#name":"keyword"  "$":{"id":"pc_S4uMW9yg8f"}  "$$":[{"#name":"text"  "_":"Alpha Feto Protein  BMI"}  {"#name":"keyword"  "$":{"id":"pc_RX1m20fd13"}  "$$":[{"#name":"text"  "_":"Body Mass Index
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号